125 related articles for article (PubMed ID: 34298587)
21. Systemic Adaptive Immune Parameters Associated with Neuroblastoma Outcomes: the Significance of Gamma-Delta T Cells.
Gozlan EC; Chobrutskiy BI; Zaman S; Yeagley M; Blanck G
J Mol Neurosci; 2021 Nov; 71(11):2393-2404. PubMed ID: 33666857
[TBL] [Abstract][Full Text] [Related]
22. Bacterial Sequencing Reads in Blood Exome Files from Melanoma and Cervical Cancer Patients are Associated with Cancer Recurrence.
Quach JU; Diaz MJ; Huda TI; Kinskey JC; Zaman S; Desantis JE; Cios KJ; Blanck G
Mol Biotechnol; 2023 Sep; 65(9):1476-1484. PubMed ID: 36653589
[TBL] [Abstract][Full Text] [Related]
23. Specific TCR V-J gene segment recombinations leading to the identification pan-V-J CDR3s associated with survival distinctions: diffuse large B-cell lymphoma.
Cios KJ; Huda TI; Eakins RA; Mihyu MM; Blanck G
Leuk Lymphoma; 2022 Jun; 63(6):1314-1322. PubMed ID: 35019822
[TBL] [Abstract][Full Text] [Related]
24. T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates.
Roca AM; Chobrutskiy BI; Callahan BM; Blanck G
Hum Immunol; 2019 Apr; 80(4):237-242. PubMed ID: 30684568
[TBL] [Abstract][Full Text] [Related]
25. TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma.
Hudock TR; Barker VR; Manley BJ; Chobrutskiy A; Chobrutskiy BI; Diaz MJ; Song JJ; Blanck G
Cancer Biomark; 2023; 38(1):103-110. PubMed ID: 37545223
[TBL] [Abstract][Full Text] [Related]
26. Electrostatic Complementarities of Glioblastoma-Resident T-Cell Receptors and Cancer Testis Antigens Linked to Poor Outcomes and High Levels of Sphingosine Kinase-2 Expression.
Arias MA; Cios KJ; Kacsoh DB; Montgomery BE; Song JJ; Patel AR; Chobrutskiy A; Chobrutskiy BI; Blanck G
Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106775
[TBL] [Abstract][Full Text] [Related]
27. TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
Arndt MF; Koohestani DM; Chobrutskiy BI; Mihyu MM; Diaz M; Gozlan EC; Yeagley M; Zaman S; Roca AM; Blanck G
Hum Immunol; 2020 Dec; 81(12):692-696. PubMed ID: 32950267
[TBL] [Abstract][Full Text] [Related]
28. Detection of Productively Rearranged TcR-α V-J Sequences in TCGA Exome Files: Implications for Tumor Immunoscoring and Recovery of Antitumor T-cells.
Gill TR; Samy MD; Butler SN; Mauro JA; Sexton WJ; Blanck G
Cancer Inform; 2016; 15():23-8. PubMed ID: 26966347
[TBL] [Abstract][Full Text] [Related]
29. IGL CDR3 Hydropathy and Antigen Chemical Complementarity Associated with Greater Disease-Free Survival in Lung Adenocarcinoma: Implications for Gender Disparities.
Charkowick SV; Huda TI; Patel DN; Yeagley M; Arturo JF; Cios KJ; Gozlan EC; Chobrutskiy A; Chobrutskiy BI; Blanck G
Biochem Genet; 2024 Feb; 62(1):530-546. PubMed ID: 37392243
[TBL] [Abstract][Full Text] [Related]
30. Specific Intratumor Bacteria Genera and TRG Recombinations Associated with Greater Survival Probability in Alimentary Tract Cancers.
Zaman S; Chobrutskiy BI; Quach JU; Blanck G
J Gastrointest Cancer; 2023 Dec; 54(4):1300-1307. PubMed ID: 37103748
[TBL] [Abstract][Full Text] [Related]
31. Immunogenomics Parameters for Patient Stratification in Alzheimer's Disease.
Huda TI; Diaz MJ; Gozlan EC; Chobrutskiy A; Chobrutskiy BI; Blanck G
J Alzheimers Dis; 2022; 88(2):619-629. PubMed ID: 35662120
[TBL] [Abstract][Full Text] [Related]
32. Tumor Resident, B-Cell Receptor Chemical Characteristics Associated with Better Overall Survival for Neuroblastoma.
Kacsoh DB; Patel DN; Hsiang M; Gozlan EC; Chobrutskiy A; Chobrutskiy BI; Blanck G
J Mol Neurosci; 2022 Sep; 72(9):2011-2019. PubMed ID: 35896862
[TBL] [Abstract][Full Text] [Related]
33. Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival rates.
Huda TI; Mihyu M; Gozlan EC; Arndt MF; Diaz MJ; Zaman S; Chobrutskiy BI; Blanck G
Leuk Lymphoma; 2021 Jul; 62(7):1711-1720. PubMed ID: 33622167
[TBL] [Abstract][Full Text] [Related]
34. RNASeqBrowser: a genome browser for simultaneous visualization of raw strand specific RNAseq reads and UCSC genome browser custom tracks.
An J; Lai J; Wood DL; Sajjanhar A; Wang C; Tevz G; Lehman ML; Nelson CC
BMC Genomics; 2015 Mar; 16(1):145. PubMed ID: 25766521
[TBL] [Abstract][Full Text] [Related]
35. Immune DNA signature of T-cell infiltration in breast tumor exomes.
Levy E; Marty R; Gárate Calderón V; Woo B; Dow M; Armisen R; Carter H; Harismendy O
Sci Rep; 2016 Jul; 6():30064. PubMed ID: 27452728
[TBL] [Abstract][Full Text] [Related]
36. High-throughput, sliding-window algorithm for assessing chemical complementarity between immune receptor CDR3 domains and cancer mutant peptides: TRG-PIK3CA interactions and breast cancer.
Chobrutskiy BI; Chobrutskiy A; Zaman S; Yeagley M; Huda TI; Blanck G
Mol Immunol; 2021 Jul; 135():247-253. PubMed ID: 33933816
[TBL] [Abstract][Full Text] [Related]
37. Finding the lost treasures in exome sequencing data.
Samuels DC; Han L; Li J; Quanghu S; Clark TA; Shyr Y; Guo Y
Trends Genet; 2013 Oct; 29(10):593-9. PubMed ID: 23972387
[TBL] [Abstract][Full Text] [Related]
38. Profiling model T-cell metagenomes with short reads.
Warren RL; Nelson BH; Holt RA
Bioinformatics; 2009 Feb; 25(4):458-64. PubMed ID: 19136549
[TBL] [Abstract][Full Text] [Related]
39. VDJML: a file format with tools for capturing the results of inferring immune receptor rearrangements.
Toby IT; Levin MK; Salinas EA; Christley S; Bhattacharya S; Breden F; Buntzman A; Corrie B; Fonner J; Gupta NT; Hershberg U; Marthandan N; Rosenfeld A; Rounds W; Rubelt F; Scarborough W; Scott JK; Uduman M; Vander Heiden JA; Scheuermann RH; Monson N; Kleinstein SH; Cowell LG
BMC Bioinformatics; 2016 Oct; 17(Suppl 13):333. PubMed ID: 27766961
[TBL] [Abstract][Full Text] [Related]
40. Chemical complementarity between immune receptors and cancer mutants, independent of antigen presentation protein binding, is associated with increased survival rates.
Hsiang M; Chobrutskiy BI; Diaz M; Huda TI; Creadore S; Zaman S; Cios KJ; Gozlan EC; Blanck G
Transl Oncol; 2021 Jun; 14(6):101069. PubMed ID: 33780706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
